» Articles » PMID: 37545895

Platelet-rich Plasma in the Pathologic Processes of Tendinopathy: a Review of Basic Science Studies

Overview
Date 2023 Aug 7
PMID 37545895
Authors
Affiliations
Soon will be listed here.
Abstract

Tendinopathy is a medical condition that includes a spectrum of inflammatory and degenerative tendon changes caused by traumatic or overuse injuries. The pathological mechanism of tendinopathy has not been well defined, and no ideal treatment is currently available. Platelet-rich plasma (PRP) is an autologous whole blood derivative containing a variety of cytokines and other protein components. Various basic studies have found that PRP has the therapeutic potential to promote cell proliferation and differentiation, regulate angiogenesis, increase extracellular matrix synthesis, and modulate inflammation in degenerative tendons. Therefore, PRP has been widely used as a promising therapeutic agent for tendinopathy. However, controversies exist over the optimal treatment regimen and efficacy of PRP for tendinopathy. This review focuses on the specific molecular and cellular mechanisms by which PRP manipulates tendon healing to better understand how PRP affects tendinopathy and explore the reason for the differences in clinical trial outcomes. This article has also pointed out the future direction of basic research and clinical application of PRP in the treatment of tendinopathy, which will play a guiding role in the design of PRP treatment protocols for tendinopathy.

Citing Articles

Effect of platelet-rich plasma on angiogenic and regenerative properties in patients with critical limb ischemia.

Tanzadehpanah H, Nobari S, Hoseini A, Ghotbani F, Mehrabzadeh M, Jalili Shahri J Regen Ther. 2025; 28:517-526.

PMID: 39995496 PMC: 11848493. DOI: 10.1016/j.reth.2025.01.008.


Use of platelet-rich plasma in rheumatic diseases.

Yessirkepov M, Fedorchenko Y, Zimba O, Mukanova U Rheumatol Int. 2024; 45(1):13.

PMID: 39739042 DOI: 10.1007/s00296-024-05776-1.


Arthroscopic procedures for degenerative rotator cuff disease: a systematic review and network meta-analysis.

Feng Z, Wu S, Hu H, Long H, Zhou L, Shen M J Orthop Surg Res. 2024; 19(1):650.

PMID: 39402591 PMC: 11475212. DOI: 10.1186/s13018-024-05129-5.


Effectiveness of Percutaneous Needle Tenotomy for Tendinopathies: A Systematic Review.

Maag L, Linder S, Hackett L, Mitchkash M, Farley T, Lamar D Sports Health. 2024; :19417381241275659.

PMID: 39238190 PMC: 11569693. DOI: 10.1177/19417381241275659.


Mechanisms, Efficacy, and Clinical Applications of Platelet-Rich Plasma in Tendinopathy: A Comprehensive Review.

Kale P, Patel H, Jaiswal A Cureus. 2024; 16(7):e65636.

PMID: 39205774 PMC: 11350620. DOI: 10.7759/cureus.65636.


References
1.
Chan B, Chan K, Maffulli N, Webb S, Lee K . Effect of basic fibroblast growth factor. An in vitro study of tendon healing. Clin Orthop Relat Res. 1997; (342):239-47. View

2.
Saltzman B, Jain A, Campbell K, Mascarenhas R, Romeo A, Verma N . Does the Use of Platelet-Rich Plasma at the Time of Surgery Improve Clinical Outcomes in Arthroscopic Rotator Cuff Repair When Compared With Control Cohorts? A Systematic Review of Meta-analyses. Arthroscopy. 2016; 32(5):906-18. DOI: 10.1016/j.arthro.2015.10.007. View

3.
Del Buono A, Battery L, Denaro V, Maccauro G, Maffulli N . Tendinopathy and inflammation: some truths. Int J Immunopathol Pharmacol. 2011; 24(1 Suppl 2):45-50. DOI: 10.1177/03946320110241S209. View

4.
de Vos R, Weir A, van Schie H, Bierma-Zeinstra S, Verhaar J, Weinans H . Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010; 303(2):144-9. DOI: 10.1001/jama.2009.1986. View

5.
Li H, Hua Y . Achilles Tendinopathy: Current Concepts about the Basic Science and Clinical Treatments. Biomed Res Int. 2016; 2016:6492597. PMC: 5112330. DOI: 10.1155/2016/6492597. View